marimed inc mrmd a leading multistate cannabis operator focused on improving lives every day today announced its financial results for the first quarter ended march 31 2022 “i am very pleased with our solid financial results this past quarter despite a slowdown in our industry coupled with rising inflation in the us” bob fireman the company’s ceo said “we are executing on our strategic growth plan as evidenced by the recent closings of both our maryland and illinois acquisitions we will continue delivering on our promises to our shareholders including maintaining our standing as one of the best stewards of capital in our industry”   revenue from retail dispensary operations grew 41 compared to the first quarter of 2021 which was driven by a new dispensary in metropolis illinois and higher customer counts in both illinois and massachusetts   revenue from wholesale operations grew 6 compared to the first quarter of 2021 as a result of both the increased production from marimed’s manufacturing facility and the increased number of licensed dispensary clients in massachusetts   revenue from licensing management fees and real estate income increased 2 compared to the first quarter of 2021 as a result of the continued success of the company’s awardwinning brands that are licensed in seven states and puerto rico as well as growth in the company’s managed businesses   nongaap ebitda came in positive at 89 million compared to a 76 million gain in the same quarter of 2021   nongaap adj ebitda came in positive at 104 million versus 803 million in the prior year’s quarter “we ended the first quarter with a cash balance of 335 million and generated positive cash flow from operations of 85 million” jon levine cfo of marimed said “our strong firstquarter financials during an industrywide slowdown gives us the confidence we will meet or beat our financial guidance for 2022”   gross margin in line with fiscal 2021 gross margin of 54 to 55